Skip to main content
. 2019 Aug 12;71(9):1553–1570. doi: 10.1002/art.40906

Figure 2.

Figure 2

A, Main characteristics of the 2 clusters (cluster A and cluster B) of patients with systemic sclerosis (SSc). B, Left, Proportions of each cluster with the main clinical characteristics of diffuse cutaneous SSc (dcSSc), restrictive defect, and suspected pulmonary hypertension (PH) on echocardiography (echo). Right, Peak modified Rodnan skin thickness score (MRSS), mortality (per 1,000 patient‐years [py]), and percentages of patients with anticentromere antibodies (ACAs) and anti–topoisomerase I (anti–topo I) antibodies in each cluster. C, Kaplan‐Meier survival curves for the 2 clusters. D, Forest plot showing mortality hazard ratios and 95% confidence intervals for the 2 clusters. Broken line shows the hazard ratio for the reference group. Green symbols represent cluster A; orange symbols represent cluster B. DU = digital ulcer; ILD = interstitial lung disease.